Sales: $1.7 billion (estimated)
Key Personnel: Bris Rocher, chairman and chief executive officer.
Major Products: Skin care and cosmetics. Brands include Yves Rocher, Petit Bateau, Stanhome, Dr Pierre Ricaud, Daniel Jouvance, Kiotis and ID Parfums.
New Products: Deep Wrinkle Expert Care Day-Night, On-Target Filler Eye Wrinkle Solution, Face & Body Comfort Cream, Pure System (daily exfoliating cleanser, clarifying toner, stop blemish lotion, pore clearing mask, blemish corrector, pure system cleansing duo and pore clearing mask), Restorative Lip Balm with shea butter, Moisturizing Lip Balm with grape extract.
Comments: The company distributes 300 million products in more than 80 countries. In recent weeks, privately-held Yves Rocher has been rumored to be a takeover target by Coty.
Just last month, Sanofi sold its 19.3% stake in the Yves Rocher Group to Société Financière des Laboratoires de Cosmétologie Yves Rocher, subject to certain closing conditions. Upon closing of this transaction, which is expected to take place before the end of the third quarter, the Rocher family will control more than 95% of the Group’s capital. The sale price was not undisclosed.
Sanofi acquired a stake in the Yves Rocher Group’s capital in 1973 and divested part of its stake in the early 2000s.
“We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years,” said Jérôme Contamine, executive vice president, chief financial officer, Sanofi. “The decision to divest is in line with the Group’s objectives to focus on its strategic activities.”
At this year’s FiFi Awards, the fragrance industry’s annual salute to itself, Yves Rocher North America’s Comme une Evidence Green won the Direct To Consumer Men category.